Chronic lymphocytic leukemia

Highlights in Chronic Lymphocytic Leukemia From the 65th ASH Annual Meeting and Exposition

A Review of Selected Presentations From ASH 2023  December 9-12, 2023   •   San Diego, California   Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic […]